Magnetic resonance imaging connectivity features associated with response to transcranial magnetic stimulation in major depressive disorder
(2024)
Journal Article
Briley, P., Webster, L., Boutry, C., Oh, H., Auer, D., Liddle, P., & Morriss, R. (2024). Magnetic resonance imaging connectivity features associated with response to transcranial magnetic stimulation in major depressive disorder. Psychiatry Research: Neuroimaging, 342, Article 111846. https://doi.org/10.1016/j.pscychresns.2024.111846
Transcranial magnetic stimulation (TMS) is an FDA-approved neuromodulation treatment for major depressive disorder (MDD), thought to work by altering dysfunctional brain connectivity pathways, or by indirectly modulating the activity of subcortical b... Read More about Magnetic resonance imaging connectivity features associated with response to transcranial magnetic stimulation in major depressive disorder.